William Blair Issues Pessimistic Forecast for AXSM Earnings

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Investment analysts at William Blair dropped their Q4 2025 earnings estimates for Axsome Therapeutics in a research note issued to investors on Tuesday, November 26th. William Blair analyst M. Minter now expects that the company will post earnings of $0.10 per share for the quarter, down from […]

Leave a Reply

Your email address will not be published.

Previous post Ashtead Group plc (OTCMKTS:ASHTF) Short Interest Up 82.9% in November
Next post Q3 EPS Estimate for Franklin Resources Decreased by Analyst